Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Receivables (2016 - 2025)

Historic Receivables for Acadia Healthcare Company (ACHC) over the last 16 years, with Q3 2025 value amounting to $452.8 million.

  • Acadia Healthcare Company's Receivables rose 337.82% to $452.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $452.8 million, marking a year-over-year increase of 337.82%. This contributed to the annual value of $389.7 million for FY2024, which is 136.46% down from last year.
  • According to the latest figures from Q3 2025, Acadia Healthcare Company's Receivables is $452.8 million, which was up 337.82% from $431.3 million recorded in Q2 2025.
  • Acadia Healthcare Company's Receivables' 5-year high stood at $452.8 million during Q3 2025, with a 5-year trough of $284.9 million in Q1 2021.
  • Its 5-year average for Receivables is $366.9 million, with a median of $364.2 million in 2023.
  • Its Receivables has fluctuated over the past 5 years, first tumbled by 1945.32% in 2021, then soared by 2322.1% in 2024.
  • Quarter analysis of 5 years shows Acadia Healthcare Company's Receivables stood at $292.1 million in 2021, then increased by 15.63% to $337.8 million in 2022, then rose by 16.94% to $395.1 million in 2023, then fell by 1.36% to $389.7 million in 2024, then grew by 16.21% to $452.8 million in 2025.
  • Its last three reported values are $452.8 million in Q3 2025, $431.3 million for Q2 2025, and $421.6 million during Q1 2025.